The prestigious PharmaTimes Marketer of the Year competition closes for entries in a matter of weeks. It only takes a few seconds to fill out the online entry form and you don’t need to do anything else until the day of
read moreA Texas man who turned a drug diversion scheme into a $50 million business has bought himself a 15-year jail sentence. More: Head of Cumberland Distribution gets 15-year sentence for drug diversion scam Source: fierce
read moreGlaxoSmithKline has upped its expectations for the year after a strong performance by its vaccines division in the second quarter and the delay of a potential generic version of Advair in the US. More: GSK ups guidance and unveils major
read moreMSD’s Keytruda significantly extended overall survival when used as monotherapy for first-line treatment of recurrent or metastatic head and neck squamous cell carcinoma (HNSCC) in patients expressing PD-L1. More: Keytruda extends survival in first-line head and neck cancer trial Source:
read moreMedicines commonly prescribed to dementia patients have been linked to an increase in harmful side-effects, according to new research involving the University of Exeter and King’s College London. More: Opioid analgesics, Z-drugs linked to harmful effects in dementia patients Source:
read moreViiV Healthcare has unveiled positive clinical data for two two-drug HIV regimens ay the 22nd International AIDS conference in Amsterdam, showing long-term efficacy and non-inferiority to a current standard of care. More: ViiV unveils positive data for two-drug HIV regimens
read more© 1994 - 2026 B.M. Pharmaceuticals